Delivery Order SPE2DX22D0010-SPE2D826FBJ67
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, valued at $4,817.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,513.64 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units). This competitive award with firm fixed pricing represents a non-set-aside contract and is scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Methylphenidate ER tablets in 36-milligram dosage. This is a firm fixed-price delivery order with a ceiling value of $3,312.60 and an ultimate completion date of December 8, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for methylphenidate ER 27 mg tablets (100 count) with a ceiling value of $1,851.44. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 5, 2025. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on May 13, 2025, to supply Methylphenidate ER 18 mg tablets in a quantity of 100 units. The contract is valued at $2,319.50 and carries a firm fixed price with an ultimate completion date of May 14, 2025. This award is classified as a non-set-aside, competitively awarded delivery order and represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,020.56 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Methylphenidate ER Tablets 18mg. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 20, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger $999.999 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, with a ceiling value of $1,176.87 and a firm fixed price structure. The order is scheduled for completion by November 28, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100s, with a ceiling value of $3,038.08 under a firm fixed-price arrangement. This delivery order represents a non-set-aside competitive award with an ultimate completion date of December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency Medical Supply Chain awarded a competitive delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Methylphenidate ER Tablets 18mg, a controlled-release formulation commonly used in the treatment of attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $6,390.70, carries an ultimate completion date of November 6, 2025, and represents a non-set-aside procurement. The award was issued under...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBJ67Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Methylphenidate ER Tablets 18mg under a firm fixed-price contract valued at $3,505.40, with completion required by December 1, 2025. This non-set-aside competitive award will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, operates as a child contract under a larger indefinite delivery vehicle with the Defense Logistics Agency Troop Support Medical. AmerisourceBergen Drug Corp maintains a significant prime indefinite delivery contract (SPE2DX) valued at $999.99 million through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. This delivery order for methylphenidate represents one of numerous pharmaceutical procurements the company fulfills through its federal contracting relationships, which support critical medical supply chains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with medications spanning multiple therapeutic domains including neurological treatments, pain management, and specialty pharmaceuticals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/27/25 |